anti-DR5 agonist monoclonal antibody TRA-8
Term · Oncology and biomedicine · MLC-T-ONC-010583
An agonist mouse monoclonal antibody directed against TRAIL death receptor type 5 (DR5) with potential antineoplastic activity. Anti-DR5 agonist monoclonal antibody TRA-8 binds DR5, which may induce apoptosis in DR5-expressing tumor cells. DR5 is a tumor cell surface ligand that crosslinks with death receptor type 4 (DR4) when bound by TRAIL [Tumor necrosis (TNF)-related apoptosis-inducing ligand], triggering apoptosis via a death receptor signaling pathway. The apoptotic activity of this antibody may not require DR4/DR5 crosslinking.
| Identifier | MLC-T-ONC-010583 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | anti-death receptor 5 agonist monoclonal antibody TRA-8 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-010583",
"term": "anti-DR5 agonist monoclonal antibody TRA-8",
"field": "Oncology and biomedicine",
"definition": "An agonist mouse monoclonal antibody directed against TRAIL death receptor type 5 (DR5) with potential antineoplastic activity. Anti-DR5 agonist monoclonal antibody TRA-8 binds DR5, which may induce apoptosis in DR5-expressing tumor cells. DR5 is a tumor cell surface ligand that crosslinks with death receptor type 4 (DR4) when bound by TRAIL [Tumor necrosis (TNF)-related apoptosis-inducing ligand], triggering apoptosis via a death receptor signaling pathway. The apoptotic activity of this antibody may not require DR4/DR5 crosslinking.",
"synonyms": [
"anti-death receptor 5 agonist monoclonal antibody TRA-8"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/anti-dr5-agonist-monoclonal-antibody-tra-8/"
}
Record 1,679 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.